评估系统和大脑的药物动力学参数,以重新定位使用静脉注射玻尿酸注射的甲福林
Sejal Sharma1, Yong Zhang1, Dhavalkumar Patel2
1Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, Texas; Center for Blood-Brain Barrier Research and Brain Drug Discovery, Texas Tech University Health Sciences Center, Amarillo, Texas.
The Journal of pharmacology and experimental therapeutics
|February 1, 2025
概括
这项研究确定了大脑中甲胺的关键药理学参数,这对于了解其在治疗中风和神经退行性疾病方面的潜力至关重要. 它强调了在临床前研究中使用相关剂量的重要性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 甲胺在治疗缺血性中风和神经退行性疾病方面表现有前途.
- 关于在相关临床前剂量下甲双的全身和脑药动力学 (PK) 参数存在重大知识差距.
研究的目的:
- 为了在临床前研究中确定大脑中甲福尔的关键PK参数.
- 强调使用药理学上相关剂量的重要性,以研究甲胺在神经疾病中的作用.
主要方法:
- 开发并验证了一种液体色谱-并联质谱法,用于在血,大脑和脑脊液中量化甲福明.
- 对大脑组织结合和代谢稳定性进行了体外测试.
- 在剂量范围和评估的大脑PK参数 (K_in,Kp,uu,大脑) 中给小鼠静脉注射甲福明.
主要成果:
- 甲胺在血或大脑中没有显著的结合,并且在代谢上稳定.
- 观察到快速进入大脑,在5分钟内检测到水平.
- 确定了1.87 ± 0.27μL/g/min的单向血液至大脑常数 (K_in). 不结合的大脑与血的比率 (K_p,uu,大脑) 随着剂量增加而下降,表明和,但绝对的大脑度继续上升.
- 甲胺在脑脊液中被检测到,但度低于大脑.
结论:
- 这项研究提供了大脑中甲胺的必不可少的PK数据,解决了神经学研究的关键差距.
- 选择适当的,药理上相关的剂量对于准确的临床前评估梅特福林在中风和神经退行性疾病中的疗效至关重要.
- 这些发现支持在疾病模型中进一步研究甲胺的PK/PD,为潜在的治疗应用奠定了基础.
相关概念视频
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
153
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
153
01:18Two-Compartment Open Model: IV Bolus Administration
384
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
384
01:09One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
187
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
187
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
58
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
58
01:13Bioavailability: Overview
2.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.7K
00:59Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
36
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
36